C25365Level 4

Description

**Semantic type:** Intellectual Product

**Definition:** A written or verbal account, representation, statement, or explanation of something.

**Synonyms:** - DESCR - Desc - Descriptive - Descriptor - description - description

GET/api/v1/systems/nci_thesaurus/nodes/C25365

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C117883Which Diagnostic Criteria Met

C126068Observational Study Sampling Method Description

C126072Retained Biospecimen Description

C126075Substudy Details

C127802Study Protocol Uniform Resource Locator Description

C142434Clinical Outcomes Assessment Context of Use

C142704Study Description

C147139Study Design Description

C161312Evidence of Malignant Disease Description

C164318Adverse Event Grade Description

C164648Timing Description

C164653Transition Description

C164749Data Monitoring Committee Charter Version Description

C164781Device Parameter Description

C164893Pathway Description

C164939Performed Imaging Study Description

C165035Planned Experimental Unit Allocation Result Description

C165054Project Description

C165104Statistical Analysis Plan Version Description

C165122Stratum Group Description

C165138Study Outcome Measure Description

C165237Treatment Assignment Description

C166209Cohort Description

C166231Lesion Description

C166273Program Full Description

C166275Program Short Description

C170568Sponsor Device Description

C170999Normal or Reference Range Description

C171190Electronic File Description

C176359Vaginal Bleeding and/or Spotting Frequency Description

C177931Intervention Description

C178287Anaplasia Descriptor

C178288Vascular Invasion Descriptor

C181527Condom Use Frequency

C188812Workflow Item Description

C188824Study Endpoint Description

C188828Study Arm Data Origin Description

C188834Study Design Element Description

C188835Transition Rule Description

C188836Clinical Encounter Description

C188846Clinical Study Data Description

C188849Workflow Description

C188854Analysis Population Description

C188856Intercurrent Event Description

C198212Distribution Pattern Finding Description

C200473Tumor Depth Descriptor

C200474Tumor Shape Observed Descriptor

C201316Biomedical Concept Category Description

C201320Biomedical Concept Surrogate Description

C201324Procedure Description

C201332Schedule Timeline Description

C204098Study Outcome Description

C207453Scheduled Instance Description

C207459Administration Duration Description

C207463Agent Administration Description

C207475Characteristic Description

C207481Condition Description

C207486Study Eligibility Criteria Description

C207497Study Governance Date Description

C207505Study Masking Description

C207517Population Definition Description

C207561Study Protocol Document Description

C207564Study Site Description

C207575Syntax Template Description

C207579Syntax Template Dictionary Description

C207647Study Intervention Description

C215523Estimand Description

C215541Subject Enrollment Description

C215560Study Definition Document Description

C215574Administrable Product Definition Description

C215587Substance Description

C215591Substance Strength Description

C215597Assigned Person Description

C215601Study Role Description

C215605Study Change Description

C215615Medical Device Description

C215623Product Organization Role Description

C215649Eligibility Criterion Item Description

C216996Study Amendment Description

C218472Study Risk and Mitigation Strategy Description

C218483Description of Protocol Change

C218692Protocol Approval Method Description

C218695Amendment Scope Enrollment Description

C218714Alternate Description of Planned Duration of Trial Intervention

C218717Alternate Description of Planned Duration of Trial Participation

C218725Overall Risk-Benefit Assessment Description

C218726Description of Trial Duration

C218727Description of Level and Method of Blinding

C218728Additional Description of Trial Design

C218739Description of Trial Population and Rationale

C218747Trial Intervention Overview or Informational Table Header

C218751Description of Investigational Trial Intervention

C218758Investigational Trial Intervention Adherence Measures Description

C218759Description of Noninvestigational Trial Intervention

C218761Description of Other Noninvestigational Trial Intervention

C218769Trial Assessments and Procedures Considerations Description

C218770Screening Assessments and Procedures Description

C218771Baseline Assessments and Procedures Description

C218772Efficacy Assessments and Procedures Description

C218773Safety Assessments and Procedures Description

C218785Safety Event Situational Scope Description

C218801Description of the Participants Included in Data Analysis

C218802Description of Trial Baseline Variable Analysis

C218815Description of Assent Process

C218816Description of Emergency Consent Process

C218819Committee Description

C218834Country and/or Region-Specific Protocol Clarifications Description

C218838Additional Description of Duration

C219658Description of Method of Assignment to Trial Intervention

C222329Description of Background Trial Intervention

C222330Description of Rescue Therapy

C222675Identification of Source Records Description

C226237Treatment Vehicle Structured Description

C69207Selected Region Description

C71140Document Detailed Description

C71141Document Summary Description

C83412Unplanned Subject Element Description

C88009Unplanned Subject Visit Description

C90335Mass Description

C90477Samples for Toxicokinetic Analysis Indicator

C93531Citation Description

C93562Enhancement Description

C93588Link Page Description

C93589Location Description

C93626Planned Study Subject Experience

C93636Public Description

C93669Scientific Description

C93725Animal Description

C93728Arm Description

C93752Defined Activity Description

C93824Epoch Description

C93859Material Description

C93870Organization Description

C93996Planned Activity Description

C94090Study Objective Description

C94258Expanded Access Study Protocol Intervention Or Procedure

C94262Interventional Study Protocol Version Intervention Or Procedure

C95109Hair or Fur Cover

C95332Defined Medical Condition Result

C95338Active Ingredient Dose Description

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue